Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metastatic Cancers
Clinical trial NCT05204147 · RECRUITING
Trial details
- NCT number
- NCT05204147
- Sponsor
- City of Hope Medical Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-02
- Primary completion
- 2026-07-21
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.